Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials.
Journal: The journal of headache and pain
Published: March 01, 2021
A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention.
Journal: Cephalalgia : an international journal of headache
Published: November 24, 2020
The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% Response.
Journal: Headache
Published: June 04, 2020
Efficacy and safety of erenumab in women with a history of menstrual migraine.
Journal: The journal of headache and pain
Published: March 06, 2020
Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraine.
Journal: BMC neurology
Published: February 15, 2020
One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study.
Journal: Neurology
Published: August 01, 2019
Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications.
Journal: The journal of headache and pain
Published: May 06, 2019
A Controlled Trial of Erenumab for Episodic Migraine.
Journal: The New England journal of medicine
Published: November 25, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026